White & Case advises TPG on refinancing of iNova Pharmaceuticals

Press Release
|
1 min read

Global law firm White & Case LLP has advised TPG on the refinancing of its portfolio company iNova Pharmaceuticals, a leading independent consumer healthcare and medicine products company.

"Following the recent refinancing of Novotech, we are pleased to again work with the TPG team on this transaction," said White & Case partner Mark Wesseldine, who led the Firm's deal team. "The deal is another example of the White & Case team’s proven strength in supporting top tier sponsors and their financing needs across Asia-Pacific."

The White & Case team which advised on the transaction was led by partner Mark Wesseldine (Sydney) and included partners Roman Picherack (Sydney) and Charles McConnell (Singapore), local partner Nate Crowley (Hong Kong), counsel Igor Golshtein (Melbourne) and associates Greig Lamont, Brianna Edwards (both Sydney), John Tan and Ammellia Fu (both Singapore). 

Press contact
For more information please speak to your local media contact.

Top